Philipp Blanke, MD, a Jonathan R. Weir-McCall, MBCHB, PHD, b Stephan Achenbach, MD,
c Victoria Delgado, MD, PHD, d Jörg Hausleiter, MD, e Hasan Jilaihawi, MD, f Mohamed …

Reliable estimates of the long-term outcomes of acute kidney injury (AKI) are needed to
inform clinical practice and guide allocation of health care resources. This systematic review …

Background Patients with severe aortic stenosis and a small aortic annulus are at risk for
impaired valvular hemodynamic performance and associated adverse cardiovascular …

Background Among low-risk patients with severe, symptomatic aortic stenosis who are
eligible for both transcatheter aortic-valve implantation (TAVI) and surgical aortic-valve …

Background The benefit of percutaneous coronary intervention (PCI) in patients with stable
coronary artery disease and severe aortic stenosis who are undergoing transcatheter aortic …

Abstract Background and Aims Transcatheter aortic valve implantation (TAVI) has become a
viable treatment option for patients with severe aortic valve stenosis across a broad range of …

Abstract Aims The Valve Academic Research Consortium (VARC), founded in 2010, was
intended to (i) identify appropriate clinical endpoints and (ii) standardize definitions of these …

Background In low surgical risk patients with symptomatic severe aortic stenosis, the
PARTNER 3 (Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low …

Importance Transcatheter aortic valve implantation (TAVI) is a less invasive alternative to
surgical aortic valve replacement and is the treatment of choice for patients at high operative …

Background We aimed to assess the safety of edoxaban in combination with P2Y12
inhibition in patients with atrial fibrillation who had percutaneous coronary intervention (PCI) …